Stay updated on Nivolumab and RT in Localized Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and RT in Localized Bladder Cancer Clinical Trial page.

Latest updates to the Nivolumab and RT in Localized Bladder Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check37 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed information about a phase II trial for nivolumab in treating urothelial bladder cancer, while adding new references to AJCC staging and collaborators involved in the research.SummaryDifference39%
- Check44 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check88 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check102 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1%
Stay in the know with updates to Nivolumab and RT in Localized Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and RT in Localized Bladder Cancer Clinical Trial page.